Food for thought: formulating away the food effect – a PEARRL review

No abstract is available for this paper.

• Publication year

  2019

• Venue

  The Journal of pharmacy and pharmacology

• Publication date

  2019-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jphp.12957PMID 29956330
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review

  2019cited by this paper
• Exploring gastric emptying rate in minipigs: Effect of food type and pre‐dosing of metoclopramide

  2018cited by this paper
• To Take or Not to Take With Meals? Unraveling Issues Related to Food Effects Labeling for Oral Antineoplastic Drugs

  2018influential reference
• Development Considerations for Nanocrystal Drug Products

  2017cited by this paper
• Food Effect on Oral Bioavailability: Old and New Questions

  2017cited by this paper
• Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers

  2017cited by this paper
• Glass‐forming ability of compounds in marketed amorphous drug products

  2017cited by this paper
• Food, gastrointestinal pH, and models of oral drug absorption

  2017cited by this paper
• Food effect: The combined effect of media pH and viscosity on the gastrointestinal absorption of ciprofloxacin tablet

  2017cited by this paper
• Enhanced oral bioavailability and diminished food effect of lurasidone hydrochloride nanosuspensions prepared by facile nanoprecipitation based on dilution

  2017cited by this paper
• Patent Review of Manufacturing Routes to Recently Approved PARP Inhibitors: Olaparib, Rucaparib, and Niraparib

  2017cited by this paper
• Preparation and Characterization of the Sulfobutylether-β-Cyclodextrin Inclusion Complex of Amiodarone Hydrochloride with Enhanced Oral Bioavailability in Fasted State

  2017cited by this paper
• 50years of oral lipid-based formulations: Provenance, progress and future perspectives.

  2016cited by this paper
• A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption—Part I: Gastrointestinal pH

  2016cited by this paper
• A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption—Part I: Gastrointestinal pH

  2016cited by this paper
• Quality-by-design based development of a self-microemulsifying drug delivery system to reduce the effect of food on Nelfinavir mesylate.

  2016cited by this paper
• Prediction of positive food effect: Bioavailability enhancement of BCS class II drugs.

  2016cited by this paper
• Methodology of oral formulation selection in the pharmaceutical industry.

  2016cited by this paper
• Navigating the human gastrointestinal tract for oral drug delivery: Uncharted waters and new frontiers.

  2016cited by this paper
• Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.

  2016cited by this paper
• The Effect of Food on the Intraluminal Behavior of Abiraterone Acetate in Man.

  2016cited by this paper
• A Review: Pharmaceutical and Pharmacokinetic Aspect of Nanocrystalline Suspensions.

  2016cited by this paper
• Oral nanomedicine approaches for the treatment of psychiatric illnesses.

  2016cited by this paper
• Enhanced oral bioavailability of lurasidone by self-nanoemulsifying drug delivery system in fasted state

  2016cited by this paper
• Effect of food intake and co-administration of placebo self-nanoemulsifying drug delivery systems on the absorption of cinnarizine in healthy human volunteers.

  2016cited by this paper
• Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro.

  2016cited by this paper
• Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments.

  2015cited by this paper
• Formulation development and systematic optimization of stabilized ziprasidone hydrochloride capsules devoid of any food effect

  2015cited by this paper
• Food-associated stimuli enhance barrier properties of gastrointestinal mucus.

  2015influential reference
• Food Effect in Humans: Predicting the Risk Through In Vitro Dissolution and In Vivo Pharmacokinetic Models

  2015cited by this paper
• Effect of Food on the Pharmacokinetics of Olaparib after Oral Dosing of the Capsule Formulation in Patients with Advanced Solid Tumors

  2015cited by this paper
• Evaluation of the use of Göttingen minipigs to predict food effects on the oral absorption of drugs in humans.

  2015cited by this paper
• Nanomemulsion of megestrol acetate for improved oral bioavailability and reduced food effect

  2015cited by this paper
• Amorphous solid dispersion technique for improved drug delivery: basics to clinical applications

  2015cited by this paper
• Is oral absorption of vigabatrin carrier-mediated?

  2015cited by this paper
• Clinical Pharmacokinetic Studies of Enzalutamide

  2015cited by this paper
• Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects

  2015cited by this paper
• Reduced Food-Effect on Intestinal Absorption of Dronedarone by Self-microemulsifying Drug Delivery System (SMEDDS).

  2015cited by this paper
• Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumours

  2015cited by this paper
• Exploring the Impact of Drug Properties on the Extent of Intestinal Lymphatic Transport - In Vitro and In Vivo Studies

  2015cited by this paper
• Effects of food on pharmacokinetics of immediate release oral formulations of aspirin, dipyrone, paracetamol and NSAIDs – a systematic review

  2015cited by this paper
• Validating speed of onset as a key component of good analgesic response in acute pain

  2014cited by this paper
• Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases.

  2014cited by this paper
• Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state.

  2014cited by this paper
• A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption.

  2014cited by this paper
• Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI.

  2014cited by this paper
• The effects of a high‐fat meal on single‐dose vemurafenib pharmacokinetics

  2014cited by this paper
• Bio-predictive tablet disintegration: effect of water diffusivity, fluid flow, food composition and test conditions.

  2014influential reference
• Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).

  2014cited by this paper
• Human and simulated intestinal fluids as solvent systems to explore food effects on intestinal solubility and permeability.

  2014cited by this paper
• Improved Oral Bioavailability of BCS Class 2 Compounds by Self Nano-Emulsifying Drug Delivery Systems (SNEDDS): The Underlying Mechanisms for Amiodarone and Talinolol

  2013cited by this paper
• Strategies to Address Low Drug Solubility in Discovery and Development

  2013cited by this paper
• Food, physiology and drug delivery.

  2013cited by this paper
• Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.

  2013cited by this paper
• Mechanistic understanding of food effects: water diffusivity in gastrointestinal tract is an important parameter for the prediction of disintegration of solid oral dosage forms.

  2013cited by this paper
• Comparative pharmacokinetic profiles of a novel isotretinoin formulation (isotretinoin-Lidose) and the innovator isotretinoin formulation: a randomized, 4-treatment, crossover study.

  2013cited by this paper
• Exploring food effects on indinavir absorption with human intestinal fluids in the mouse intestine.

  2013cited by this paper
• Playing Russian Roulette With Tyrosine Kinase Inhibitors

  2013cited by this paper
• The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.

  2013cited by this paper
• Drug nanocrystals in the commercial pharmaceutical development process.

  2013cited by this paper
• Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers

  2012cited by this paper
• Fast and flawed or scientifically sound: the argument for administering oral oncology drugs during fasting.

  2012cited by this paper
• In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations.

  2012cited by this paper
• The effect of food on the oral bioavailability of drugs: a review of current developments and pharmaceutical technologies for pharmacokinetic control.

  2012cited by this paper
• A formulation strategy for gamma secretase inhibitor ELND006, a BCS class II compound: development of a nanosuspension formulation with improved oral bioavailability and reduced food effects in dogs.

  2012cited by this paper
• Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

  2012influential reference
• Food-Drug Interactions

  2012cited by this paper
• Solid nanocrystalline dispersions of ziprasidone with enhanced bioavailability in the fasted state.

  2012cited by this paper
• Mechanistic investigation of food effect on disintegration and dissolution of BCS class III compound solid formulations: the importance of viscosity

  2012cited by this paper
• NSAIDs: take with food or after fasting?

  2012cited by this paper
• Hybrid nanomaterials that mimic the food effect: controlling enzymatic digestion for enhanced oral drug absorption.

  2012cited by this paper
• Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids.

  2011cited by this paper
• Flushing oral oncology drugs down the toilet.

  2011cited by this paper
• Gastrointestinal contents in fasted state and post-lipid ingestion: in vivo measurements and in vitro models for studying oral drug delivery.

  2011cited by this paper
• Gastrointestinal contents in fasted state and post-lipid ingestion: in vivo measurements and in vitro models for studying oral drug delivery.

  2011cited by this paper
• Application of Dissolution/Permeation System for Evaluation of Formulation Effect on Oral Absorption of Poorly Water-Soluble Drugs in Drug Development

  2011cited by this paper
• Improved Ziprasidone Formulations with Enhanced Bioavailability in the Fasted State and a Reduced Food Effect

  2011cited by this paper
• Correlation between the systemic clearance of drugs and their food effects in humans

  2011cited by this paper
• Principles of early drug discovery

  2011cited by this paper
• The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil.

  2010cited by this paper
• Prediction of food effect by bile micelles on oral drug absorption considering free fraction in intestinal fluid.

  2010cited by this paper
• Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

  2010cited by this paper
• How to improve R&D productivity: the pharmaceutical industry's grand challenge

  2010cited by this paper
• Influence of dietary substances on intestinal drug metabolism and transport.

  2010cited by this paper
• Food and Oral Antineoplastics: More Than Meets the Eye

  2010cited by this paper
• Inconsistent Labeling of Food Effect for Oral Agents across Therapeutic Areas: Differences between Oncology and Non-Oncology Products

  2010cited by this paper
• Oral Cancer Chemotherapy: The Critical Interplay Between Patient Education and Patient Safety

  2010cited by this paper
• Meal-Induced Acceleration of Tablet Transit Through the Human Small Intestine

  2009cited by this paper
• Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol.

  2009cited by this paper
• HIGHLIGHTS OF PRESCRIBING INFORMATION

  2009cited by this paper
• Analysis of Drug Interactions Involving Fruit Beverages and Organic Anion‐Transporting Polypeptides

  2009cited by this paper
• Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states.

  2009cited by this paper
• Postprandial Changes in Solubilizing Capacity of Human Intestinal Fluids for BCS Class II Drugs

  2009cited by this paper
• Reply to I.F. Tannock

  2009cited by this paper
• Gut instincts: explorations in intestinal physiology and drug delivery.

  2008cited by this paper
• Development of a self-emulsifying formulation that reduces the food effect for torcetrapib.

  2008cited by this paper
• Current Methods for Predicting Human Food Effect

  2008cited by this paper
• Understanding the Effect of API Properties on Bioavailability Through Absorption Modeling

  2008cited by this paper
• Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

  2008influential reference
• Clinical Pharmacokinetics of XP13512, a Novel Transported Prodrug of Gabapentin

  2008cited by this paper

• Evaluation of Food Effects on Two Anticancer Drugs in Humans: Application of Physiologically Based Pharmacokinetic Modeling as a Surrogate Strategy to Minimize In-Vivo Studies in Drug Development

  2026cites this paper
• An Expert's View on the Application of TIM Technology in the Development of Oral Drug Products.

  2026cites this paper
• PBPK Modeling Addresses Oral Absorption-Mediated Drug Interactions.

  2026cites this paper
• Solidified ionic liquid-based formulations of metformin with enhanced GI epithelial permeability.

  2025cites this paper
• Predicting the pharmacokinetics and food effect of oral drug products using the dynamic gastrointestinal model (DGM).

  2025cites this paper
• Improving accuracy in food effect Predictions: Application of In-Vitro absorption experiments as a useful tool for the evaluation of ten drug products.

  2025cites this paper
• Pharmacokinetics and Safety of a Fixed‐Dose Combination of Alogliptin and Extended‐Release Metformin Under Fasting and/or Fed Conditions in Healthy Adults

  2025cites this paper
• Small molecule drug absorption in inflammatory bowel disease and current implementation in physiologically- based pharmacokinetic models.

  2025cites this paper
• Evaluation of hygienic food handling practices and associated factors among food handlers in the Amhara region, Ethiopia: a systematic review and meta-analysis

  2025cites this paper
• Evaluation of Solubility-Limited Absorption as a Surrogate to Predicting Positive Food Effect of BCS II/IV Drugs

  2025cites this paper
• Solubility-Limited Absorption Identified by a Simplified PBPK Model for the Prediction of Positive Food Effect for BCS II/IV Drugs

  2025cites this paper
• Abiraterone acetate fixed-dosed combinations with ibuprofen-based therapeutic eutectic and deep eutectic solvents.

  2025cites this paper
• Application of an Interdisciplinary Approach to Form Selection in Drug Development

  2025cites this paper
• Effect of Food Intake or Coadministration With an Acid‐Reducing Agent on Lenacapavir Pharmacokinetics Following Oral Administration

  2025cites this paper
• Assessment of Pharmacokinetics and Food Effect of AD‐109, a Novel Formulation of Rivaroxaban 18 mg

  2025cites this paper
• Zoonotic Pathogens in Food: New Advances and Editorial Insights

  2025cites this paper
• An overview on developing the formulation to keep away the food impact on absorption

  2025cites this paper
• Machine learning to predict food effects during drug development: a comprehensive review

  2025cites this paper
• Synthesis, In vitro Characterization and Biopharmaceutical Evaluation of a Novel Phosphate Prodrug of Sorafenib.

  2025cites this paper
• Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs.

  2024cites this paper
• Key Factors for Improving Predictive Accuracy and Avoiding Overparameterization of the PBPK Absorption Model in Food Effect Studies of Weakly Basic Water-Insoluble Compounds in Immediate Release Formulations

  2024cites this paper
• Do dietary interventions exert clinically important effects on the bioavailability of β-lactam antibiotics? A systematic review with meta-analyses

  2024cites this paper
• The effect of food on the pharmacokinetics of Sutetinib maleate capsule, an irreversible EGFR tyrosine kinase inhibitor, in healthy Chinese subjects

  2024influential citation
• Predicting gastric emptying of drug substances taken under postprandial conditions by combination of biorelevant dissolution and mechanistic in silico modeling.

  2024cites this paper
• Rationalizing Counterion Selection for the Development of Lipophilic Salts: A Case Study with Venetoclax

  2024cites this paper
• DDID: a comprehensive resource for visualization and analysis of diet–drug interactions

  2024cites this paper
• Drug Nanocrystals in Oral Absorption: Factors That Influence Pharmacokinetics

  2024cites this paper
• Lipid based formulations as supersaturating oral delivery systems: from current to future industrial applications.

  2023cites this paper
• Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants

  2023cites this paper
• Prandial state and biological sex modulate clinically relevant efflux transporters to different extents in Wistar and Sprague Dawley rats.

  2023cites this paper
• Usefulness of the BioGIT system in screening for differences in early exposure in the fasted state on an a priori basis.

  2023cites this paper
• Assessment of food effects during clinical development.

  2023cites this paper
• Fed Intestinal Solubility Limits and Distributions Applied to the Developability Classification System.

  2023cites this paper
• Effect of Food on the Pharmacokinetics of Limertinib (ASK120067) and its Main Metabolite in Healthy Chinese Volunteers

  2023cites this paper
• Cardiovascular Remodeling Post-Ischemia: Herbs, Diet, and Drug Interventions

  2023cites this paper
• Recent Approaches of Matrix Release Tablet in NDDS System

  2023cites this paper
• Analysis of the interplay of physiological response to food intake and drug properties in food-drug interactions.

  2023cites this paper
• Applications of Modeling and Simulation Approaches in Support of Drug Product Development of Oral Dosage Forms and Locally Acting Drug Products: a Symposium Summary

  2023cites this paper
• In vitro and in silico methods to investigate the effect of moderately increasing medium viscosity and density on ibuprofen dissolution rate.

  2023cites this paper
• Evaluation of Food Effect on the Pharmacokinetics of Velufenacin, a New Muscarinic Receptor Antagonist, in Healthy Subjects

  2023cites this paper
• Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

  2022cites this paper
• Bridging the Gap between Food Effects under Clinical Trial Conditions and Real Life: Modeling Delayed Gastric Emptying of Drug Substances and Gastric Content Volume Based on Meal Characteristics.

  2022cites this paper
• Food effects on gastrointestinal physiology and drug absorption.

  2022cites this paper
• When Interactions Between Bile Salts and Cyclodextrin Cause a Negative Food Effect: Dynamic Dissolution/Permeation Studies with Itraconazole (Sporanox®) and Biomimetic Media.

  2022cites this paper
• Relative Bioavailability and Food Effect of GSK3640254 Tablet and Capsule Formulations in Healthy Participants

  2022cites this paper
• Improving the dissolution behaviors and bioavailability of abiraterone acetate via multicomponent crystal forms.

  2022cites this paper
• Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms

  2022cites this paper
• Bio-enabling strategies to mitigate the pharmaceutical food effect: a mini review.

  2022cites this paper
• Pharmacokinetics and Bioequivalence of Single‐Oral‐Dose Linagliptin: A Randomized, 2‐Period Crossover Trial in Chinese Healthy Subjects Under Fasting and Fed Conditions

  2022cites this paper
• Reduced the Food Effect and Enhanced the Oral Bioavailability of Ivacaftor by Self-Nanoemulsifying Drug Delivery System (SNEDDS) Using a New Oil Phase

  2022cites this paper
• An Open Label, Phase 1, Randomized, Seven-treatment, Seven-period, Crossover Study to Assess the Relative Bioavailability, pH Effect, Food Effect, and Dose Proportionality of CC-292, a Potent and Orally Available Bruton’s Tyrosine Kinase Inhibitor

  2022cites this paper
• Applications of bio-predictive dissolution tools for the development of solid oral dosage forms: current industry experience

  2022cites this paper
• Food-Drug Interactions - A Short Review of the Particularities of Pharmacokinetics and Pharmacodynamics Molecular Stage Correlations

  2022cites this paper
• Comparison of a single pharmaceutical surfactant versus intestinal biorelevant media for etravirine dissolution: role and impact of micelle diffusivity.

  2022cites this paper
• The effect of dietary fibers on the absorption of oral hypoglycemic drugs: a systematic review of controlled trials

  2022cites this paper
• Intra-and inter-subject variability in gastric pH following a low-fat, low-calorie meal.

  2022cites this paper
• Клинически значимые взаимодействия лекарственных средств с фруктовыми и ягодными соками

  2021cites this paper
• Understanding Mechanisms of Food Effect and Developing Reliable PBPK Models Using a Middle-out Approach

  2021cites this paper
• Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network.

  2021cites this paper
• Oral biopharmaceutics tools: recent progress from partnership through the Pharmaceutical Education and Research with Regulatory Links collaboration.

  2021cites this paper
• Combining species specific in vitro & in silico models to predict in vivo food effect in a preclinical stage - case study of Venetoclax.

  2021cites this paper
• Re-thinking functional food development through a holistic approach

  2021cites this paper
• Clinical investigation of the biopharmaceutical characteristics of nifurtimox tablets - implications for quality control and application.

  2021cites this paper
• The Impact of Diet and Exercise on Drug Responses

  2021cites this paper
• Investigation of Self-Emulsifying Drug-Delivery System Interaction with a Biomimetic Membrane under Conditions Relevant to the Small Intestine

  2021cites this paper
• Overcoming the Low Oral Bioavailability of Deuterated Pyrazoloquinolinone Ligand DK-I-60-3 by Nanonization: A Knowledge-Based Approach

  2021cites this paper
• Nanoparticulate Drug Delivery Strategies to Address Intestinal Cytochrome P450 CYP3A4 Metabolism towards Personalized Medicine

  2021cites this paper
• Lipophilic salts and lipid-based formulations for bridging the food effect gap of venetoclax.

  2021cites this paper
• Machine Learning Methods for Prediction of Food Effects on Bioavailability: A Comparison of Support Vector Machines and Artificial Neural Networks.

  2021cites this paper
• A Non-Nutritive Feeding Intervention Alters the Expression of Efflux Transporters in the Gastrointestinal Tract

  2021cites this paper
• Knowledge, Attitude and Practice of Physicians and Pharmacists Working in Alexandria Governmental Hospitals Regarding Food Drug and Drug Nutrient Interactions

  2021cites this paper
• Потенциальные взаимодействия лекарственных средств и чеснока

  2021cites this paper
• Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions

  2021cites this paper
• Machine Learning predicts the effect of food on orally administered medicines.

  2021cites this paper
• Comparison of Predictions by BCS, rDCS and Machine Learning for the Effect of Food on Oral Drug Absorption Based on Features Calculated In silico

  2021influential citation
• Special Populations

  2021cites this paper
• Impact of Anatomy and Physiology

  2021cites this paper
• Best practices in current models mimicking drug permeability in the gastrointestinal tract - an UNGAP review.

  2021cites this paper
• Exploring the Relationship of Drug BCS Classification, Food Effect, and Gastric pH-Dependent Drug Interactions

  2021cites this paper
• Drug–Nutrient Interactions

  2021cites this paper
• Computational study on interindividual variability in composition of dog intestinal fluids and its effect on the solubilization pattern for poorly soluble drugs

  2021cites this paper
• Drug–Nutrient Interactions

  2020cites this paper
• Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective

  2020cites this paper
• Effect of excipients on oral absorption process according to the different gastrointestinal segments

  2020cites this paper
• A Retrospective Biopharmaceutical Analysis of >800 Approved Oral Drug Products: Are Drug Properties of Solid Dispersions and Lipid-Based Formulations Distinctive?

  2020cites this paper
• Food Effects on Oral Drug Absorption: Application of Physiologically-Based Pharmacokinetic Modeling as a Predictive Tool

  2020influential citation
• Chase Dosing of Lipid Formulations to Enhance Oral Bioavailability of Nilotinib in Rats

  2020cites this paper
• Supersaturated-Silica Lipid Hybrids Improve in Vitro Solubilization of Abiraterone Acetate

  2020cites this paper
• Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate.

  2020cites this paper
• Vanillin enhances the passive transport rate and absorption of drugs with moderate oral bioavailability in vitro and in vivo by affecting the membrane structure.

  2020cites this paper
• Drug-Nutrition Interactions in Infectious Diseases

  2020cites this paper
• Modeling and Simulation of Process Technology for Nanoparticulate Drug Formulations—A Particle Technology Perspective

  2020cites this paper
• Applying Computational Predictions of Biorelevant Solubility Ratio upon Self-Emulsifying Lipid-Based Formulations Dispersion to Predict Dose Number.

  2020cites this paper
• Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients

  2020cites this paper
• Negative Food Effect of Danirixin: Use of PBPK Modelling to Explore the Effect of Formulation and Meal Type on Clinical PK

  2020cites this paper
• The prediction of food effect on drug oral absorption by machine learning

  2020cites this paper
• Biopharmaceutical Characteristics of Nifurtimox Tablets for Age‐ and Body Weight‐Adjusted Dosing in Patients With Chagas Disease

  2020cites this paper
• Combining biorelevant in vitro and in silico tools to simulate and better understand the in vivo performance of a nano-sized formulation of aprepitant in the fasted and fed states.

  2019cites this paper
• Toward the establishment of a standardized pre-clinical porcine model to predict food effects – Case studies on fenofibrate and paracetamol

  2019cites this paper
• The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP group.

  2019cites this paper